We are live on !
Find out more
CH
CVI Holdings Portfolio holdings
AUM
$116M
Turnover
40.21%
1-Year Est. Return
5.68%
This Fund
S&P 500
This Quarter Est. Return
-7.91%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$9.8M
(+9.2%)
Cap. Flow
+$11.9M
Cap. Flow % of AUM
Cap. Flow %
10.25%
Top 10 Holdings %
Top 10 Hldgs %
77.9%
Holding
189
New
31
Increased
1
Reduced
48
Closed
45
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Skye Bioscience
SKYE
|
+$8.07M |
| 2 |
INmune Bio
INMB
|
+$5.88M |
| 3 |
GP-Act III Acquisition Corp Units
GPATU
|
+$4.63M |
| 4 |
AZZ Inc
AZZ
|
+$3.22M |
| 5 |
Flag Ship Acquisition Corp Unit
FSHPU
|
+$3.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spire Global
SPIR
|
+$3.13M |
| 2 |
Erasca
ERAS
|
+$3M |
| 3 |
SDCL EDGE Acquisition Corporation
SEDA
|
+$2.55M |
| 4 |
IB Acquisition Corp. Unit
IBACU
|
+$2.5M |
| 5 |
Achieve Life Sciences
ACHV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 46.25% |
| 2 | Miscellaneous | 18.47% |
| 3 | Healthcare | 15.17% |
| 4 | Financials | 14.14% |
| 5 | Industrials | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Flutter Entertainment
FLUT
$13.1B
| $53.6M | 46.25% |
294,180
| – | – |
2024 Q1
1 quarter
|
|
|
2
Skye Bioscience
SKYE
$6.86M
| $5.44M | 4.69% |
+84,967
| New | +$8.07M |
2024 Q2
0 quarters
|
|
|
3
INmune Bio
INMB
$43.6M
| $5.26M | 4.54% |
+596,372
| New | +$5.88M |
2024 Q2
0 quarters
|
|
|
4
GP-Act III Acquisition Corp Units
GPATU
| $4.61M | 3.98% |
+460,000
| New | +$4.63M |
2024 Q2
0 quarters
|
|
|
5
AZZ Inc
AZZ
$3.89B
| $3.18M | 2.74% |
+41,191
| New | +$3.22M |
2024 Q2
0 quarters
|
|
|
6
Flag Ship Acquisition Corp Unit
FSHPU
| $3.14M | 2.71% |
+314,000
| New | +$3.14M |
2024 Q2
0 quarters
|
|
|
7
IB Acquisition Corp
IBAC
$54.4M
| $2.49M | 2.15% |
+250,000
| New | +$2.49M |
2024 Q2
0 quarters
|
|
8
DELISTED
Haymaker Acquisition Corp 4
HYAC
| $2.36M | 2.04% |
224,617
-32,237
| -13% | -$338K |
2023 Q4
2 quarters
|
|
|
ANSC
9
DELISTED
Agriculture & Natural Solutions Acquisition Corp
ANSC
| $2.07M | 1.78% |
201,955
-97,818
| -33% | -$1M |
2024 Q1
1 quarter
|
|
|
UCFI
10
CN Healthy Food Tech Group
UCFI
| $1.93M | 1.67% |
+192,000
| New | +$1.93M |
2024 Q2
0 quarters
|
|
|
BAYA
11
DELISTED
Bayview Acquisition Corp
BAYA
| $1.47M | 1.27% |
+143,732
| New | +$1.47M |
2024 Q2
0 quarters
|
|
12
DELISTED
Trailblazer Merger Corp I
TBMC
| $1.4M | 1.21% |
130,000
| – | – |
2023 Q2
4 quarters
|
|
13
Nyxoah
NYXH
$113M
| $1.29M | 1.11% |
+183,590
| New | +$1.74M |
2024 Q2
0 quarters
|
|
14
DELISTED
Goldenstone Acquisition Limited Common Stock
GDST
| $1.23M | 1.06% |
109,890
| – | – |
2022 Q2
8 quarters
|
|
15
DELISTED
CARGO Therapeutics
CRGX
| $1.15M | 0.99% |
+70,000
| New | +$1.33M |
2024 Q2
0 quarters
|
|
16
DELISTED
Nabors Energy Transition Corp II
NETD
| $1.15M | 0.99% |
109,134
-82,324
| -43% | -$866K |
2023 Q4
2 quarters
|
|
17
DELISTED
Bukit Jalil Global Acquisition 1
BUJA
| $1.08M | 0.93% |
100,000
| – | – |
2023 Q3
3 quarters
|
|
|
DYCQU
18
DELISTED
DT Cloud Acquisition Corp Unit
DYCQU
| $1.04M | 0.89% |
100,000
| – | – |
2024 Q1
1 quarter
|
|
19
DELISTED
Keen Vision Acquisition Corp
KVAC
| $1.03M | 0.89% |
97,259
-38,425
| -28% | -$404K |
2023 Q4
2 quarters
|
|
20
Lionheart Holdings Unit
CUBWU
| $1M | 0.86% |
+100,000
| New | +$1000K |
2024 Q2
0 quarters
|
|
21
Melar Acquisition Corp I Unit
MACIU
| $1M | 0.86% |
+100,000
| New | +$1M |
2024 Q2
0 quarters
|
|
22
DELISTED
Oak Woods Acquisition Corp
OAKU
| $975K | 0.84% |
90,000
| – | – |
2023 Q4
2 quarters
|
|
23
DELISTED
Regulus Therapeutics
RGLS
| $716K | 0.62% |
401,012
-1,005,238
| -71% | -$2.33M |
2024 Q1
1 quarter
|
|
24
Surrozen
SRZN
$276M
| $711K | 0.61% |
+64,905
| New | +$670K |
2024 Q2
0 quarters
|
|
25
DELISTED
TMT Acquisition Corp Ordinary Shares
TMTC
| $692K | 0.6% |
+63,061
| New | +$686K |
2024 Q2
0 quarters
|
|
Similar funds
EL
YSP
GIM
FWM
CPG
WCM
ETIA
RCM
CVI Holdings's Q2 2024 Portfolio in Review
As of Q2 2024, CVI Holdings held 189 positions worth $116M, up 9.2% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
CVI Holdings deployed $11.9M of net new capital in Q2 2024, opening 31 new positions and adding to 1 existing holding. Its largest new stake was Skye Bioscience: 84,967 shares worth $5.44M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 55% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Achieve Life Sciences, an estimated $2.39M trimmed.
- CVI Holdings's largest Q2 2024 buy was Skye Bioscience: 84,967 shares worth $5.44M.
- CVI Holdings added most to RTB Digital in Q2 2024, an estimated $151K increase.
- CVI Holdings's biggest Q2 2024 reduction was Achieve Life Sciences, cutting an estimated $2.39M.
- CVI Holdings fully exited Spire Global in Q2 2024, selling an estimated $3.13M.
- CVI Holdings's ten largest holdings make up 78% of its $116M portfolio in Q2 2024.
- CVI Holdings opened 31 new positions and closed 45 in Q2 2024.
- CVI Holdings's portfolio value rose 9.2% quarter-over-quarter to $116M.
Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.